Abstract
In recent years, coagulase-negative staphylococci (CoNS) have been increasingly recognised as causative agents of various infections, especially in immunocompromised patients and related to implanted foreign body materials. In this study, rpoB sequencing was used for simultaneous species identification and detection of rifampicin resistance in clinical staphylococci isolates. Forty-nine (96%) out of 51 isolates, representing 17 different Staphylococcus species according to the initial phenotypic species identification, were identified to the species level using rpoB sequencing. Furthermore, the two remaining isolates were Kocuria sp. and Corynebacterium sp. respectively, according to 16S rRNA sequencing. Comparison with the phenotypic diagnostics also revealed that 8 (16%) of the 49 isolates differed regarding identified species. Discrepant analysis confirmed the result of the rpoB sequencing for all except 2 of these isolates, which could not be distinguished as single species using 16S rRNA sequencing. Regarding detection of rifampicin resistance, isolates obtained pre- and post-treatment with rifampicin were examined. These isolates comprised S. aureus (7 patients) and S. lugdunensis (1 patient). Rifampicin resistance was mainly detected following short-term treatment with rifampicin in combination with isoxazolyl-penicillin, or long-term treatment with rifampicin and ciprofloxacin. Each rifampicin-resistant isolate displayed an identical rpoB sequence as their corresponding rifampicin-susceptible isolates except for one (n = 6) or two (n = 1) nonsynonymous single nucleotide polymorphisms, or insertion of one codon (n = 1). In conclusion, rpoB sequencing is a rapid, objective and accurate method of species identification and simultaneous detection of rifampicin resistance in staphylococci.
Similar content being viewed by others
References
Mellmann A, Becker K, von Eiff C, Keckevoet U, Schumann P, Harmsen D (2006) Sequencing and staphylococci identification. Emerg Infect Dis 12:333–336
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532
Huebner J, Goldmann DA (1999) Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 50:223–236
Von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677–685
Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R et al (2005) Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56:331–336
Drinkovic D, Morris AJ, Pottumarthy S, MacCulloch D, West T (2003) Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 52:820–825
Widmer AF, Frei R, Rajacic Z, Zimmerli W (1990) Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162:96–102
Zimmerli W (1995) Role of antibiotics in the treatment of infected joint prosthesis. Orthopade 24:308–313
Aubry-Damon H, Soussy CJ, Courvalin P (1998) Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 42:2590–2594
Wehrli W (1983) Rifampin: mechanisms of action and resistance. Rev Infect Dis 5 [Suppl 3]:S407–S411
Jin DJ, Gross CA (1988) Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 202:45–58
Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PR et al (1998) Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42:1853–1857
Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y et al (1998) Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 42:621–628
Becker K, Harmsen D, Mellmann A, Meier C, Schumann P, Peters G et al (2004) Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J Clin Microbiol 42:4988–4995
Kwok AY, Su SC, Reynolds RP, Bay SJ, Av-Gay Y, Dovichi NJ et al (1999) Species identification and phylogenetic relationships based on partial HSP60 gene sequences within the genus Staphylococcus. Int J Syst Bacteriol 49:1181–1192
Calvo J, Hernandez JL, Farinas MC, Garcia-Palomo D, Aguero J (2000) Osteomyelitis caused by Staphylococcus schleiferi and evidence of misidentification of this Staphylococcus species by an automated bacterial identification system. J Clin Microbiol 38:3887–3889
Drancourt M, Raoult D (2002) rpoB gene sequence-based identification of Staphylococcus species. J Clin Microbiol 40:1333–1338
Poyart C, Quesne G, Boumaila C, Trieu-Cuot P (2001) Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target. J Clin Microbiol 39:4296–4301
Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoult D (2000) 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol 38:3623–3630
Trulzsch K, Grabein B, Schumann P, Mellmann A, Antonenka U, Heesemann J et al (2007) Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol 57:1543–1548
Van de Peer Y, De Wachter R (1994) TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 10:569–570
Unemo M, Olcén P, Albert J, Fredlund H (2003) Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization. J Clin Microbiol 41:4141–4147
Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D et al (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442–5448
Goh SH, Santucci Z, Kloos WE, Faltyn M, George CG, Driedger D et al (1997) Identification of Staphylococcus species and subspecies by the chaperonin 60 gene identification method and reverse checkerboard hybridization. J Clin Microbiol 35:3116–3121
Devriese LA, Vancanneyt M, Baele M, Vaneechoutte M, De Graef E, Snauwaert C et al (2005) Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol 55:1569–1573
Sasaki T, Kikuchi K, Tanaka Y, Takahashi N, Kamata S, Hiramatsu K (2007) Reclassification of phenotypically identified Staphylococcus intermedius strains. J Clin Microbiol 45:2770–2778
O’Neill AJ, Huovinen T, Fishwick CW, Chopra I (2006) Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother 50:298–309
Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K et al (2006) Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 12:47–50
Wichelhaus TA, Schafer V, Brade V, Boddinghaus B (1999) Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43:2813–2816
Simon GL, Smith RH, Sande MA (1983) Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases. Rev Infect Dis 5 [Suppl 3]:S507–S508
Zavasky DM, Sande MA (1998) Reconsideration of rifampin: a unique drug for a unique infection. JAMA 279:1575–1577
Berdal JE, Skramm I, Mowinckel P, Gulbrandsen P, Bjornholt JV (2005) Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 11:843–845
Soriano A, Garcia S, Bori G, Almela M, Gallart X, Macule F et al (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930–933
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537–1541
Peterson LR, Quick JN, Jensen B, Homann S, Johnson S, Tenquist J et al (1990) Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonization. Arch Intern Med 150:2151–2155
Acknowledgements
We wish to express our appreciation of B. Christensson, Å. Nilsdotter and B. Isaksson for kindly providing S. aureus strains.
This study was supported by grants from the Örebro County Council Research Committee, Sweden.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hellmark, B., Söderquist, B. & Unemo, M. Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene. Eur J Clin Microbiol Infect Dis 28, 183–190 (2009). https://doi.org/10.1007/s10096-008-0604-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-008-0604-5